Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 1,272 shares at $16.30 ($21K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Open-market sale of $21k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |
| IMVT | SELL | 2025-04-11 | $160K | — | Filing → |